Research in the pathophysiology and epidemiology of asthma has guided development of treatments that are effective in management of symptoms and improving pulmonary function in children. However, there are many significant questions that remain to be addressed about asthma management. This proposal will address two of these important issues. In the first propose a 3-year randomized, double-blind trial comparing the effects of four treatments on chronic airway obstruction in children with asthma 5-15 years of age: 1) high dose inhaled steroid (IS) + leukotriene receptor antagonist (LA), 2) high dose IS alone, 3) low dose IS + LA, and 4) low dose IS alone. Chronic airway obstruction is defined as an abnormal FEV1/FVC after maximal bronchodilation on 2 occasions separated by 6-8 weeks. Primary hypothesis: Compared to low dose IS alone, high dose IS + LA will improve post bronchodilator FEV1 and FEV1/FVC over three years of study, taking into consideration age, gender, race, duration of asthma on entry into the trial, initial FEV1, and initial FEV1/FVC. Effects of high dose IS alone and low dose IS + LA will be intermediate. In the second, we propose a nine month randomized, double-blind, placebo-controlled prospective trial comparing three therapeutic approaches to young children (1-3 years of age) with mild intermittent asthma and recurrent viral respiratory infection-induced wheezing episodes: 1) inhaled bronchodilators at inception of a URI syndrome, 2) inhaled bronchodilators and high dose nebulized inhaled steroid (IS) at inception of a URI syndrome, and 3) ongoing low dose IS with inhaled bronchodilators and high dose nebulized IS at inception of a URI syndrome. For each of the groups, if symptoms progress, as defined by development of wheezing and/or cough unresponsive to inhaled bronchodilators, oral systemic steroids will be added. Primary hypothesis: Compared with the conventional therapy consisting of the sequential addition of systemic corticosteroids to inhaled bronchodilators (Group 1), early intervention with IS at the onset of symptoms suggestive of a URI will decrease the total number of days with wheezing over a 7 month period. The administration of high dose IS at the onset of URI symptoms (Group 2) will be at least as efficacious as the administration of low dose IS as maintenance therapy with high dose IS added at first sign of URI symptoms (Group 3).

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
1U10HL064287-01
Application #
6046353
Study Section
Special Emphasis Panel (ZHL1-CSR-H (S1))
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
1999-09-30
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Washington University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Beigelman, Avraham; Bacharier, Leonard B (2016) Management of Preschool Children with Recurrent Wheezing: Lessons from the NHLBI's Asthma Research Networks. J Allergy Clin Immunol Pract 4:1-8; quiz 9-10
Israel, Elliot; Lasky-Su, Jessica; Markezich, Amy et al. (2015) Genome-wide association study of short-acting ?2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3. Am J Respir Crit Care Med 191:530-7
Gerald, Joe K; Gerald, Lynn B; Vasquez, Monica M et al. (2015) Markers of Differential Response to Inhaled Corticosteroid Treatment Among Children with Mild Persistent Asthma. J Allergy Clin Immunol Pract 3:540-6.e3
Beigelman, Avraham; Zeiger, Robert S; Mauger, David et al. (2014) The association between vitamin D status and the rate of exacerbations requiring oral corticosteroids in preschool children with recurrent wheezing. J Allergy Clin Immunol 133:1489-92, 1492.e1-3
Rabinovitch, Nathan; Mauger, David T; Reisdorph, Nichole et al. (2014) Predictors of asthma control and lung function responsiveness to step 3 therapy in children with uncontrolled asthma. J Allergy Clin Immunol 133:350-6
Beigelman, Avraham; Zeiger, Robert S; Kelly, H William et al. (2014) The challenge of treating preschool wheezing episodes: the need for evidence-based approaches. J Allergy Clin Immunol 133:1016-7
Malka, Jonathan; Mauger, David T; Covar, Ronina et al. (2014) Eczema and race as combined determinants for differential response to step-up asthma therapy. J Allergy Clin Immunol 134:483-5
Chang, Timothy S; Lemanske Jr, Robert F; Mauger, David T et al. (2014) Childhood asthma clusters and response to therapy in clinical trials. J Allergy Clin Immunol 133:363-9
Himes, Blanca E; Sheppard, Keith; Berndt, Annerose et al. (2013) Integration of mouse and human genome-wide association data identifies KCNIP4 as an asthma gene. PLoS One 8:e56179
Himes, Blanca E; Qiu, Weiliang; Klanderman, Barbara et al. (2013) ITGB5 and AGFG1 variants are associated with severity of airway responsiveness. BMC Med Genet 14:86

Showing the most recent 10 out of 41 publications